ARGS

Argos Therapeutics, Inc.
ARGS

Delisted

ARGS was delisted on the 24th of April, 2018.

4 hedge funds and large institutions have $150K invested in Argos Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-12
Holders Change %
-75%
% of All Funds
0.09%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
2
Reduced
Closed
12
Calls
$42K
Puts
Net Calls
+$42K
Net Calls Change
-$368K
Name Holding Trade Value Shares
Change
Shares
Change %
PI
1
Pharmstandard International
Luxembourg
$136K
WS
2
Wedbush Securities
California
$13K +$5.83K +35,000 +81%
MAM
3
Meeder Asset Management
Ohio
$936 +$356 +2,157 +61%
TSS
4
Two Sigma Securities
New York
-$25K -27,911 Closed
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
-$14K -15,350 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
-$10K -10,724 Closed
UBS Group
7
UBS Group
Switzerland
-$8K -9,354 Closed
AG
8
Advisor Group
Arizona
-$1K -575 Closed
APA
9
American Portfolios Advisors
New York
-$45 -50 Closed